Targeting Hepatitis B Virus cccDNA and HBx: Recent Advances and New Approaches.
Clicks: 347
ID: 51446
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
30.0
/100
347 views
37 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #9 of 28 articles by views in ACS infectious diseases
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Chronic Hepatitis B Virus (HBV) infection remains a worldwide concern and continues to be a global public health problem. Two key aspects of the HBV life cycle are essential for viral replication and thus the development of chronic infections: the establishment of the viral minichromosome, covalently closed circular (ccc) DNA, within the nucleus of infected hepatocytes, and the expression of the regulatory protein HBx. Interestingly, nuclear HBx redirects host epigenetic machinery to activate cccDNA transcription. In this Perspective, we provide an overview of recent advances in understanding the regulation of cccDNA and mechanistic and functional roles of HBx. We also describe the progress toward targeting both cccDNA and HBx for therapeutic purposes. Finally, we outline standing questions in the field and propose complementary chemical biology approaches to address them.
| Reference Key |
prescott2019targetingacs
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Prescott, Nicholas A;Bram, Yaron;Schwartz, Robert E;David, Yael; |
| Journal | ACS infectious diseases |
| Year | 2019 |
| DOI |
10.1021/acsinfecdis.9b00249
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.